Merck Global Health Innovation Fund

Corporate VC Active United States
Last updated 2026-06-18
Portfolio
2
in our dataset
Rounds participated
5
Rounds led
0
Rounds' value
$90.6M
total disclosed, rounds participated
Stages

Portfolio · 2

Investment activity

1 portfolio exit on record.

Portfolio by sector

Health Tech & Life Sciences2

Q&A

What is Merck Global Health Innovation Fund's primary sector focus?
Merck Global Health Innovation Fund primarily focuses on the Health Tech & Life Sciences sector, with all of its portfolio companies and exits falling within this area.
Can you name some notable portfolio companies of Merck Global Health Innovation Fund?
Merck Global Health Innovation Fund's portfolio includes VBL Therapeutics, which operates in targeted therapies for immune-inflammatory diseases, and medCPU, a real-time clinical decision-support platform.
Has Merck Global Health Innovation Fund had any notable exits?
Yes, Merck Global Health Innovation Fund had an exit with VBL Therapeutics in October 2014, when the company went public on NASDAQ with a valuation of $120M.
What is the typical investment range for Merck Global Health Innovation Fund?
Merck Global Health Innovation Fund typically invests between $1.3M and $40M.
When was Merck Global Health Innovation Fund founded?
Merck Global Health Innovation Fund was created in May 2019.
What kind of investor is Merck Global Health Innovation Fund?
Merck Global Health Innovation Fund is classified as a corporate venture capital firm.
When did Merck Global Health Innovation Fund make its most recent recorded investment?
Merck Global Health Innovation Fund's most recent recorded investment round occurred in February 2016.
What is the most common funding stage Merck Global Health Innovation Fund participates in?
Merck Global Health Innovation Fund has most frequently participated in B Round funding stages, with two such investments recorded.